title: Catheter-associated urinary tract infection IDSA guidelines: why the levofloxacin?
authors.forename: Larry M
authors.initials: LM
authors.lastname: Bush
authors.forename: Donald
authors.initials: D
authors.lastname: Kaye
mesh_terms: D006801:Humans; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D019072:Antibiotic Prophylaxis / Q000379:methods; D055499:Catheter-Related Infections / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D064704:Levofloxacin; D015242:Ofloxacin / Q000008:administration & dosage; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D017410:Practice Guidelines as Topic
chemical_list: D000900:Anti-Bacterial Agents; D064704:Levofloxacin; D015242:Ofloxacin